T. Funk, A. Pharris, G. Spiteri, N. Bundle, A. Melidou, Michael Carr, G. Gonzalez, Alejandro Garcia-Leon, F. Crispie, L. O’Connor, N. Murphy, J. Mossong, A. Vergison, Anke Wienecke-Baldacchino, Tamir T Abdelrahman, F. Riccardo, P. Stefanelli, A. di Martino, A. Bella, Alessandra Lo Presti, Pedro Casaca, Joana Moreno, V. Borges, J. Isidro, R. Ferreira, J. P. Gomes, L. Dotsenko, Heleene Suija, J. Epštein, O. Sadikova, H. Sepp, N. Ikonen, C. Savolainen-Kopra, S. Blomqvist, T. Möttönen, O. Helve, Joana Gomes-Dias, C. Adlhoch
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8).
Cited by 46 publications.
Field of study: Medicine